A Dis-Chem brand is seen amid a nationwide coronavirus illness (COVID-19) lockdown, at a pharmacy in Midrand, South Africa, January 18, 2021. Image taken January 18, 2021. REUTERS/Siphiwe Sibeko/File Picture Purchase Licensing Rights
JOHANNESBURG, Nov 3 (Reuters) – South African pharmacy chain Dis-Chem Pharmacies (DCPJ.J) reported a 17.2% decline in half-year earnings on Friday, nonetheless it anticipates a stronger second half, supported by progress in price management measures.
The group’s headline earnings per share, a key metric of revenue for South African firms, fell to 58.2 cents within the six months ended Aug.31 from 70.3 cents in the identical interval a 12 months earlier.
“The constrained financial setting, larger rates of interest and prices related to load-shedding has resulted in a weaker efficiency by the group,” the corporate stated.
Within the present monetary 12 months, Dis-Chem has additionally been impacted by the bottom results of the prior 12 months’s efficiency, when the first-half outcomes had been aided by acquisitions and COVID-19 vaccine administration and testing providers.
Dis-Chem reported a 9.4% rise in income to 17.9 billion rand ($975.31 million) with retail income up 8.1% to fifteen.6 billion rand and comparable pharmacy retailer income up by 5.9%.
Wholesale income grew by 13.5%.
Dis-Chem, which competes with Clicks Group (CLSJ.J), stated there shall be a specific deal with the administration of employees prices in its price management measures.
“This progress in managing the group’s largest price line represents a major step in securing constructive working leverage translating into operational revenue enhancements within the second half of monetary 12 months 2024 and over time,” the corporate stated.
($1 = 18.3531 rand)
Reporting by Nqobile Dludla; modifying by Shri Navaratnam and Jason Neely
Our Requirements: The Thomson Reuters Belief Rules.
Discover more from PressNewsAgency
Subscribe to get the latest posts sent to your email.